Exelixis (EXEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release — Positive

EXEL   Zacks Investment Research — July 21, 2025

Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Exelixis (EXEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Bank of Hawaii (BOH) Reports Next Week: Wall Street Expects Earnings Growth — Positive

BOH   Zacks Investment Research — July 21, 2025

Bank of Hawaii (BOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Bank of Hawaii (BOH) Reports Next Week: Wall Street Expects Earnings Growth

Cincinnati Financial (CINF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Cincinnati Financial (CINF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Celestica (CLS) Earnings Expected to Grow: Should You Buy? — Positive

CLS   Zacks Investment Research — July 21, 2025

Celestica (CLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Celestica (CLS) Earnings Expected to Grow: Should You Buy?

Earnings Preview: CNO Financial (CNO) Q2 Earnings Expected to Decline — Negative

CNO   Zacks Investment Research — July 21, 2025

CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: CNO Financial (CNO) Q2 Earnings Expected to Decline

Brown & Brown (BRO) Earnings Expected to Grow: Should You Buy? — Neutral

BRO   Zacks Investment Research — July 21, 2025

Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Brown & Brown (BRO) Earnings Expected to Grow: Should You Buy?

Bank of NT Butterfield & Son (NTB) Reports Next Week: Wall Street Expects Earnings Growth — Positive

NTB   Zacks Investment Research — July 21, 2025

Bank of NT Butterfield & Son (NTB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Bank of NT Butterfield & Son (NTB) Reports Next Week: Wall Street Expects Earnings Growth

Nucor (NUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release — Positive

NUE   Zacks Investment Research — July 21, 2025

Nucor (NUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Nucor (NUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for — Negative

OLN   Zacks Investment Research — July 21, 2025

Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for

Palantir's (NASDAQ: PLTR) sustained bullish run may be under threat as short interest surges, potentially derailing its push toward a record high of $160.

image for news Palantir's push to $160 under threat as PLTR short interest spikes

Earnings Preview: Nov Inc. (NOV) Q2 Earnings Expected to Decline — Negative

NOV   Zacks Investment Research — July 21, 2025

Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Nov Inc. (NOV) Q2 Earnings Expected to Decline

Principal Financial (PFG) Earnings Expected to Grow: Should You Buy? — Neutral

PFG   Zacks Investment Research — July 21, 2025

Principal Financial (PFG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Principal Financial (PFG) Earnings Expected to Grow: Should You Buy?

Woodward (WWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive

WWD   Zacks Investment Research — July 21, 2025

Woodward (WWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Woodward (WWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Alerus (ALRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral

ALRS   Zacks Investment Research — July 21, 2025

Alerus (ALRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Alerus (ALRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Analysts Estimate Potlatch (PCH) to Report a Decline in Earnings: What to Look Out for — Negative

PCH   Zacks Investment Research — July 21, 2025

Potlatch (PCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Potlatch (PCH) to Report a Decline in Earnings: What to Look Out for

LEAWOOD, Kan., July 21, 2025 (GLOBE NEWSWIRE) -- Euronet (or the “Company”) (NASDAQ: EEFT) announced today it will release second quarter 2025 earnings results prior to the market opening on Thursday, July 31, 2025. Euronet will hold a conference call the same day at 9:00 a.m. Eastern Time to discuss the results.

image for news Euronet Announces Second Quarter 2025 Earnings Release Date and Conference Call Details

CALGARY, Alberta--(BUSINESS WIRE)--DevvStream Corp. (Nasdaq: DEVS) (“DevvStream” or the “Company”), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today announced that it has entered into a securities purchase agreement for the issuance of up to (US)$300 million in senior secured convertible notes (“Senior Notes”), advancing its strategic initiative to build a blockchain-based treasury and launch a tokenization platform for sustai.

image for news DevvStream Completes $10M Initial Funding to Launch $300M Asset-Backed Digital Infrastructure and Sustainability Strategy

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2025, on Monday, August 4, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, August 05, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President an.

image for news Addus HomeCare Announces Second Quarter 2025 Earnings Release and Conference Call

DALLAS , July 21, 2025 /PRNewswire/ -- Golf fans, comedy lovers and Happy Gilmore diehards – get ready to channel your inner Happy. In celebration of the highly anticipated premiere of Happy Gilmore 2 on Netflix July 25, Topgolf has partnered up with the global streaming service to tee up an epic giveaway.

image for news Find Your Happy Place: Topgolf Celebrates the Premiere of Happy Gilmore 2 with a Limited-Edition Odyssey Hockey Stick Putter Giveaway at all U.S. Venues

ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to adequately disclose that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk.

image for news INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm